Altered concentrations of appetite regulators may contribute to the development and maintenance of HIV-associated wasting

被引:23
|
作者
Arnalich, F
Martinez, P
Hernanz, A
Gonzalez, J
Plaza, MA
Montiel, C
Pena, JM
Vazquez, JJ
机构
[1] HOSP MATERNAL LA PAZ,DEPT BIOCHEM,MADRID 28046,SPAIN
[2] HOSP MATERNAL LA PAZ,DEPT PHARMACOL,MADRID 28046,SPAIN
[3] UNIV AUTONOMA MADRID,SCH MED,MADRID,SPAIN
关键词
AIDS; anorexia; HIV-wasting; malnutrition; nutritional status; soluble tumour necrosis factor (TNF) receptors; TNF; cholecystokinin; beta-endorphin;
D O I
10.1097/00002030-199709000-00008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To examine the relation of circulating appetite neuropeptides, CCK-8 sulphate (CCK-8s) and beta-endorphin, and the tumour necrosis factor-alpha (TNF-alpha) and soluble TNF receptors (sTNFR) to the anorexia and wasting associated with HIV-infection. Design: Cross-sectional analysis. Setting: A university-based HIV/AIDS ambulatory clinic in Madrid, Spain. Participants: Thirty-six randomly selected AIDS patients without concomitant diseases or secondary infections were classified into two groups: 19 patients with wasting and 17 with normal body weight, and 18 healthy controls. Measurements: Nutritional status was evaluated by anthropometry, laboratory parameters and self-report of appetite. Plasma levels of TNF-alpha and sTNFR proteins p55 (sTNFR-p55) and p75 (sTNFR-p75) were determined by enzyme immunoassay, whereas CCK-8s and beta-endorphin levels were measured by radioimmunoassay. Results: AIDS patients with wasting had significantly higher plasma concentrations of CCK-8s, but lower levels of beta-endorphin when compared to well-nourished AIDS patients (P<0.01) or controls (P<0.001). Mean levels of TNF-alpha and sTNFR-p55 and sTNFR-p75 were greater in AIDS patients with wasting than in asymptomatic AIDS patients or in controls. No significant association was observed between any of these circulating peptides and the parameters of malnutrition. Conclusions: An activation of the TNF system, together with reciprocal changes in plasma concentrations of two neuropeptides with opposing appetite regulation, that is increased concentrations of CCK-8s but lower levels of beta-endorphin, are associated with the presence of HIV wasting. We hypothesize that these changes may contribute to the development of HIV wasting by producing a pathological inhibition of appetite.
引用
收藏
页码:1129 / 1134
页数:6
相关论文
共 50 条
  • [41] FLEXIBLE SIGMOIDOSCOPY (FS) IN EVALUATING AIDS HIV-ASSOCIATED DIARRHEA - ARE WE WASTING TIME AND RESOURCES
    LUM, DF
    HUI, SC
    CELLO, JP
    GASTROINTESTINAL ENDOSCOPY, 1993, 39 (02) : 298 - 298
  • [42] Incident HIV-Associated Wasting/Low Weight Is Associated with Nearly Doubled Mortality Risk in the Modern ART Era
    Wohlfeiler, Michael B.
    Weber, Rachel Palmieri
    Brunet, Laurence
    Siddiqui, Javeed
    Harbour, Michael
    Phillips, Amy L.
    Hayward, Brooke
    Fusco, Jennifer S.
    Hsu, Ricky K.
    Fusco, Gregory P.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2024, 40 (07) : 428 - 434
  • [43] Mammalian Cell-Derived SomatropinA Review of its Use in the Management of HIV-Associated Wasting
    David R. Goldsmith
    Antona J. Wagstaff
    Drugs, 2006, 66 : 387 - 401
  • [44] Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting
    Mulligan, K
    Schambelan, M
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2002, 85 (01) : 151 - 159
  • [45] Role of recombinant human growth hormone in HIV-Associated wasting and cachexia: Pathophysiology and rationale for treatment
    Gelato, Marie
    McNurlan, Margaret
    Freedland, Eric
    CLINICAL THERAPEUTICS, 2007, 29 (11) : 2269 - 2288
  • [46] Mammalian cell-derived somatropin - A review of its use in the management of HIV-associated wasting
    Goldsmith, DR
    Wagstaff, AJ
    DRUGS, 2006, 66 (03) : 387 - 401
  • [47] Growth hormone treatment improves muscle oxygen extraction during exercise in patients with HIV-Associated wasting
    Esposito, JG
    Ezzat, S
    Kingdon, L
    Thomas, SG
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2004, 36 (05): : S305 - S305
  • [48] Anabolic growth hormone action improves submaximal measures of physical performance in patients with HIV-associated wasting
    Esposito, JG
    Thomas, SG
    Kingdon, L
    Ezzat, S
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2005, 289 (03): : E494 - E503
  • [49] Recombinant human growth hormone in patients with HIV-associated wasting - A randomized, placebo-controlled trial
    Schambelan, M
    Mulligan, K
    Grunfeld, C
    Daar, ES
    LaMarca, A
    Kotler, DP
    Wang, J
    Bozzette, SA
    Breitmayer, JB
    Hurley, A
    Javaly, K
    Pitt, J
    Pang, M
    Heald, AE
    Shipp, KW
    Pearce, D
    Sova, K
    Pate, P
    Boswell, SL
    Flynn, T
    Polsky, B
    Haverstick, L
    Rothkopf, MM
    Bliffen, DL
    Rosenfeld, R
    Pierson, RN
    Winson, G
    Tai, V
    Bennison, WM
    Kennedy, SM
    Neu, TK
    Robinson, CE
    Schwalbert, RJ
    LaMarca, D
    Kuritzkes, DR
    Ray, MG
    Mellors, JW
    Balser, BE
    Balser, JP
    ANNALS OF INTERNAL MEDICINE, 1996, 125 (11) : 873 - +
  • [50] Biological sex determines the development of HIV-associated neurocognitive deficits
    Moidunny, Shamsudheen
    Titus, David J.
    Benneyworth, Michael A.
    Meintz, Joyce
    Thomas, Mark J.
    Ramakrishnan, Sundaram
    Atkins, ColeenM.
    Roy, Sabita
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2018, 13 : S58 - S58